Alzheimer's disease

News

UK project will trial EEG device for Alzheimer’s detection

Digital health company Cumulus Neuroscience has teamed up with two UK universities to develop its at-home electroencephalogram (EEG) headset as an early warning system for

News

BMS takes option on Prothena Alzheimer’s drug in $2.2bn deal

Bristol-Myers Squibb has upgraded a long-running alliance with Prothena in Alzheimer’s disease, taking an option on a tau protein-targeting antibody in early-stage clinica

News

Uptake of Leqembi for Alzheimer’s may be slow

Full FDA approval of Eisai and Biogen’s Alzheimer’s disease therapy Leqembi may have unlocked the door to a broader rollout of the drug and potentially blockbuster sales,

News

FDA approves first progression-slowing Alzheimer's drug

Eisai's Leqembi, marketed by Biogen, secured full FDA regulatory approval as expected

R&D

Real progress in the fight against Alzheimer’s disease

These are encouraging times in Alzheimer’s disease research and treatment.

News

CMS sheds light on its registry plan for Alzheimer’s drugs

The Centers for Medicare and Medicaid Services (CMS) in the US has provided more details about the controversial plan to require participation in a patient registry as a c

UK project will trial EEG device for Alzheimer’s detection

BMS takes option on Prothena Alzheimer’s drug in $2.2bn deal

Uptake of Leqembi for Alzheimer’s may be slow

FDA approves first progression-slowing Alzheimer's drug

Real progress in the fight against Alzheimer’s disease

CMS sheds light on its registry plan for Alzheimer’s drugs

Novo Nordisk fight with KBP Bio will go to arbitration

Discover a new era of healthcare panel engagement: Grounded ...

Alzheimer's disease

Editor's Picks